How Can Your Experience of Pregnancy and Cancer Help Others?
Patients who participate in the registry contribute to not only helping themselves, but also to providing critical data to help women worldwide make educated decisions.
If you would like to confidentially participate in an international registry that tracks the pregnancy outcomes and long-term health of women, and children of women diagnosed with cancer during pregnancy, please contact Elyce Cardonick, MD, FACOG.
Cardonick, an active member of Hope for Two’s Board of Advisors, is a maternal fetal medicine specialist who created The Cancer and Pregnancy Registry as a tool to help women diagnosed with cancer during pregnancy make difficult choices based on data and facts, not fear.
Each new patient who participates in the registry contributes to not only helping themselves, but also providing critical data to help women worldwide make educated decisions. Additionally, Cardonick is available to work with a woman’s oncologist in deciding which tests and procedures can be performed—and when—during pregnancy to maximize the safety of the unborn baby while not compromising the chance of cure of the mother.
You may reach Cardonick, as well as find out the details about participating in The Cancer and Pregnancy Registry, at www.cancerandpregnancy.com or by calling 1.877.635.4499 or 1.856.342.2491.
FDA Approves Amivantamab-Chemo Combo for Advanced NSCLC
September 19th 2024The FDA approved amivantamab-vmjw plus chemotherapy for locally advanced or metastatic non–small cell lung cancer (NSCLC) that harbors EGFR exon 19 deletions or exon 21 L858R substitution mutations whose disease has progressed on or after treatment with an EGFR TKI.
